Skip to main content
ZERIA PHARMCEUTICAL CO., LTD. logo

ZERIA PHARMCEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 4559 ISIN · JP3428850006 T Manufacturing
Open in API
Filings indexed 64 across all filing types
Latest filing 2016-08-08 Interim / Quarterly Rep…
Country JP Japan
Listing T 4559

About ZERIA PHARMCEUTICAL CO., LTD.

https://www.zeria.co.jp/english/

Zeria Pharmaceutical Co., Ltd. is a comprehensive healthcare company established in 1955. The company's operations are structured around two primary business segments: Ethical Pharmaceuticals and Consumer Healthcare. Its activities include the research, development, manufacturing, and distribution of a diverse range of products, including prescription medications, over-the-counter drugs, and other health-related goods. Zeria focuses on developing innovative pharmaceutical products to contribute to the health of people globally.

Recent filings

Filing Released Lang Actions
四半期報告書－第63期第1四半期(2016/04/01－2016/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Zeria Pharmaceutical Co., Ltd., covering the first quarter of the 63rd fiscal year (April 1, 2016, to June 30, 2016). It contains detailed financial statements, including the balance sheet, income statement, and segment information, as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-08-08 Japanese
有価証券報告書－第62期(2015/04/01－2016/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual regulatory filing for companies listed on Japanese stock exchanges. It contains comprehensive financial data, business information, and management analysis for the fiscal year ending March 31, 2016. This document is equivalent to a 10-K in the US market. FY 2016
2016-06-29 Japanese
四半期報告書－第62期第3四半期(2015/10/01－2015/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第３四半期報告書) for Zeria Pharmaceutical Co., Ltd. It contains comprehensive financial statements, including the balance sheet, income statement, and comprehensive income statement for the third quarter of the fiscal year. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2016
2016-02-10 Japanese
四半期報告書－第62期第2四半期(2015/07/01－2015/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Zeria Pharmaceutical Co., Ltd., covering the second quarter of the fiscal year ending March 31, 2016. It contains detailed financial statements, management analysis, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). Q2 2016
2015-11-06 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.